EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

FT 03 - Flash talks on Drug Allergy 1

Friday 31 May, 13:15 PM - 14:45 PM Valencia, Spain
Palma Flash Talks
13:15 000505
Procedure for provocation testing with neuromuscular blocking agents: experiences from the Danish Anaesthesia Allergy Centre
13:22 000244
Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey
13:29 000373
Development of novel MRGPRX2 antagonists as therapeutic drugs to treat non-IgE mediated allergies
13:36 000419
Patent Blue V in Peri-operative Hypersensitivity: Hidden Offender, Serial Culprit
13:43 000756
Corticosteroids hypersensitivity – a decade review
13:50 000880
Silica-nanoparticles displaying amoxicillin can efficiently and specifically activate basophils form amoxicillin-allergic patients
13:57 000977
Improving NMBA hypersensitivity management using CD203c activation marker in basophil activation tests
14:04 001364
COX-1 associated NSAIDs hypersensitivity: is etoricoxib a safe alternative?
14:11 001572
PEN-FAST score performances to evaluate the risk of positive penicillin allergy tests in a french cohort
14:18 001591
Early Use Of Intravenous Methylprednisolone Attenuates Positive Challenge Reactions During Sequential Additive Drug Challenge
14:25 001598
Inflammatory and kallikrein-kinin serum profiling of acute ACE-inhibitor angioedema
14:32 001946
Clinical Evolution Of Adults Diagnosed of Hypersensitivity Reactions To NSAIDs
14:39 001953
Clinical Evolution Of Children Diagnosed of Hypersensitivity Reactions To NSAIDs